Delivery Order SPE2DB22D2211-SPE2DB24FPGN8

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,125.61 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of 4,565,353,772 units of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. The contract has an ultimate completion date of August 6, 2024 and was awarded on August 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a delivery order under Contract SPE2DX15D1053 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,562,782,604 units of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles, with a firm fixed price ceiling of $3,274.80. The contract has an ultimate completion date of November 13, 2023. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,730.56, is for the supply of Sucralfate 1 gm/10 ml suspension in 420 ml bottles. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,339.50, is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. The contract has an ultimate completion date of October 30, 2023 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sucralfate 1 GM/10 ML Suspension, a medical product used for treating certain digestive system conditions. The contract has a ceiling value of $2,060.50 and a completion date of October 27, 2023. The contract is a firm fixed-price delivery order, with no...
The Defense Logistics Agency (DLA) awarded a $4,456.25 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 420mL of Sucralfate 1 gram/10mL suspension. This order was placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which runs through November 2026. The IDC enables AmerisourceBergen to efficiently deliver a comprehensive range of pharmaceutical products and...
The federal contract award is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $1,455.06 with a Firm Fixed Price pricing type. The period of performance runs through May 16, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,339.02, is for the delivery of 4,563,250,149 units of Sucralfate 1 GM Tablet 90S, a medication used to treat certain stomach and esophagus problems. This is a firm fixed-price delivery order contract with a period of performance through January 8, 2024. The contract is not designated as a...
This federal contract award, valued at $3,590.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. No set-aside designation was used for this contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of sucralfate 1 gram tablets. The contract has a firm fixed price and a ceiling value of $9,144.83. The period of performance extends to June 13, 2025. This contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FPGN8
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,663,747 units of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. The contract has a firm fixed price of $1,649.74 and a completion date of September 4, 2024. This contract is not a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a range of medical commodities to support military treatment programs and facilities worldwide.

Generated 12/3/24, 10:04 AM